Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,889
archived clinical trials in
Blood Cancer

Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated:  12/31/1969
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Cancer & Blood Disease Center
mi
from
Lecanto, FL
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Cancer & Blood Disease Center
mi
from
Lecanto, FL
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Associates in Oncology and Hematology
mi
from
Chattanooga, TN
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Associates in Oncology and Hematology
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
mi
from
Scottsdale, AZ
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Providence St. Joseph Medical Center
mi
from
Burbank, CA
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Providence St. Joseph Medical Center
mi
from
Burbank, CA
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
St. Jude Hospital Yorba Linda DBA, St. Joseph Heritage Healthcare
mi
from
Santa Rosa, CA
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
St. Jude Hospital Yorba Linda DBA, St. Joseph Heritage Healthcare
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Colorado Blood Cancer Institute
mi
from
Denver, CO
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Colorado Blood Cancer Institute
mi
from
Denver, CO
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Melvin And Bren Simon Cancer Center
mi
from
Indianapolis, IN
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Melvin And Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
University of Kansas Cancer Center
mi
from
Kansas City, KA
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
University of Kansas Cancer Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
NYU Clinical Cancer Center
mi
from
New York, NY
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
NYU Clinical Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
The Don & Sybil Harrington Cancer Center
mi
from
Amarillo, TX
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
The Don & Sybil Harrington Cancer Center
mi
from
Amarillo, TX
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Baylor Sammons Cancer Center
mi
from
Dallas, TX
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Baylor Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Scott & White Memorial Hospital
mi
from
Temple, TX
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Medizinische Universitat Wien
mi
from
Wien,
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Medizinische Universitat Wien
mi
from
Wien,
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
New Hope Cancer & Research Institute
mi
from
Pomona, CA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
New Hope Cancer & Research Institute
mi
from
Pomona, CA
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Medical Specialists of the Palm Beaches
mi
from
Atlantis, FL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Medical Specialists of the Palm Beaches
mi
from
Atlantis, FL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
University Cancer Institute, LLC
mi
from
Boynton Beach, FL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
University Cancer Institute, LLC
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Pasco Hernando Oncology Associates (Kumar)
mi
from
New Port Richey, FL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Pasco Hernando Oncology Associates (Kumar)
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Phoebe Putney Memorial Hospital
mi
from
Albany, GA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Phoebe Putney Memorial Hospital
mi
from
Albany, GA
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Georgia Cancer Specialists
mi
from
Atlanta, GA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Georgia Cancer Specialists
mi
from
Atlanta, GA
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Peachtree Hematology-Oncology Consultants
mi
from
Atlanta, GA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Peachtree Hematology-Oncology Consultants
mi
from
Atlanta, GA
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
US Oncology - Dublin Hematology & Oncology
mi
from
Dublin, GA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
US Oncology - Dublin Hematology & Oncology
mi
from
Dublin, GA
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Straub Clinic And Hospital
mi
from
Honolulu, HI
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Straub Clinic And Hospital
mi
from
Honolulu, HI
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Arlington
mi
from
Arlington Heights, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Arlington
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Ingalls Cancer Research Center
mi
from
Harvey, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Ingalls Cancer Research Center
mi
from
Harvey, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Elmhurst Memorial Hospital
mi
from
Lombard, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Elmhurst Memorial Hospital
mi
from
Lombard, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Oncology Specialists, S.C.
mi
from
Niles, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Oncology Specialists, S.C.
mi
from
Niles, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles
mi
from
Niles, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles
mi
from
Niles, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Illinois Cancer Care
mi
from
Peoria, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Illinois Cancer Care
mi
from
Peoria, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Orchard Research
mi
from
Skokie, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Orchard Research
mi
from
Skokie, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Carle Cancer Center
mi
from
Urbana, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Winfield
mi
from
Winfield, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Winfield
mi
from
Winfield, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Center for Cancer Care @ Goshen Health Systems
mi
from
Goshen, IN
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Center for Cancer Care @ Goshen Health Systems
mi
from
Goshen, IN
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Indiana University Cancer Center Clinical Research Office
mi
from
Indianapolis, IN
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Indiana University Cancer Center Clinical Research Office
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Cancer Care Partners, LLC
mi
from
Mishawaka, IN
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Cancer Care Partners, LLC
mi
from
Mishawaka, IN
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
Cancer Care Center
mi
from
New Albany, IN
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Cancer Care Center
mi
from
New Albany, IN
Click here to add this to my saved trials